523 related articles for article (PubMed ID: 23994756)
1. Altered gene products involved in the malignant reprogramming of cancer stem/progenitor cells and multitargeted therapies.
Mimeault M; Batra SK
Mol Aspects Med; 2014 Oct; 39():3-32. PubMed ID: 23994756
[TBL] [Abstract][Full Text] [Related]
2. Frequent gene products and molecular pathways altered in prostate cancer- and metastasis-initiating cells and their progenies and novel promising multitargeted therapies.
Mimeault M; Batra SK
Mol Med; 2011; 17(9-10):949-64. PubMed ID: 21607288
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia-inducing factors as master regulators of stemness properties and altered metabolism of cancer- and metastasis-initiating cells.
Mimeault M; Batra SK
J Cell Mol Med; 2013 Jan; 17(1):30-54. PubMed ID: 23301832
[TBL] [Abstract][Full Text] [Related]
4. New advances on critical implications of tumor- and metastasis-initiating cells in cancer progression, treatment resistance and disease recurrence.
Mimeault M; Batra SK
Histol Histopathol; 2010 Aug; 25(8):1057-73. PubMed ID: 20552555
[TBL] [Abstract][Full Text] [Related]
5. Molecular biomarkers of cancer stem/progenitor cells associated with progression, metastases, and treatment resistance of aggressive cancers.
Mimeault M; Batra SK
Cancer Epidemiol Biomarkers Prev; 2014 Feb; 23(2):234-54. PubMed ID: 24273063
[TBL] [Abstract][Full Text] [Related]
6. Frequent deregulations in the hedgehog signaling network and cross-talks with the epidermal growth factor receptor pathway involved in cancer progression and targeted therapies.
Mimeault M; Batra SK
Pharmacol Rev; 2010 Sep; 62(3):497-524. PubMed ID: 20716670
[TBL] [Abstract][Full Text] [Related]
7. Novel biomarkers and therapeutic targets for optimizing the therapeutic management of melanomas.
Mimeault M; Batra SK
World J Clin Oncol; 2012 Mar; 3(3):32-42. PubMed ID: 22442756
[TBL] [Abstract][Full Text] [Related]
8. Recent progress on normal and malignant pancreatic stem/progenitor cell research: therapeutic implications for the treatment of type 1 or 2 diabetes mellitus and aggressive pancreatic cancer.
Mimeault M; Batra SK
Gut; 2008 Oct; 57(10):1456-68. PubMed ID: 18791122
[TBL] [Abstract][Full Text] [Related]
9. Animal models relevant to human prostate carcinogenesis underlining the critical implication of prostatic stem/progenitor cells.
Mimeault M; Batra SK
Biochim Biophys Acta; 2011 Aug; 1816(1):25-37. PubMed ID: 21396984
[TBL] [Abstract][Full Text] [Related]
10. Physiological β-catenin signaling controls self-renewal networks and generation of stem-like cells from nasopharyngeal carcinoma.
Cheng Y; Cheung AK; Ko JM; Phoon YP; Chiu PM; Lo PH; Waterman ML; Lung ML
BMC Cell Biol; 2013 Sep; 14():44. PubMed ID: 24073846
[TBL] [Abstract][Full Text] [Related]
11. Incomplete cellular reprogramming of colorectal cancer cells elicits an epithelial/mesenchymal hybrid phenotype.
Hiew MSY; Cheng HP; Huang CJ; Chong KY; Cheong SK; Choo KB; Kamarul T
J Biomed Sci; 2018 Jul; 25(1):57. PubMed ID: 30025541
[TBL] [Abstract][Full Text] [Related]
12. Deadly crosstalk: Notch signaling at the intersection of EMT and cancer stem cells.
Espinoza I; Miele L
Cancer Lett; 2013 Nov; 341(1):41-5. PubMed ID: 23973264
[TBL] [Abstract][Full Text] [Related]
13. Ectopic Expression of miR-147 Inhibits Stem Cell Marker and Epithelial-Mesenchymal Transition (EMT)-Related Protein Expression in Colon Cancer Cells.
Ning X; Wang C; Zhang M; Wang K
Oncol Res; 2019 Mar; 27(4):399-406. PubMed ID: 29426374
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of Wnt/β-catenin pathway reverses multi-drug resistance and EMT in Oct4
Liu L; Zhu H; Liao Y; Wu W; Liu L; Liu L; Wu Y; Sun F; Lin HW
Biomed Pharmacother; 2020 Jul; 127():110225. PubMed ID: 32428834
[TBL] [Abstract][Full Text] [Related]
15. Pathobiological implications of the expression of EGFR, pAkt, NF-κB and MIC-1 in prostate cancer stem cells and their progenies.
Mimeault M; Johansson SL; Batra SK
PLoS One; 2012; 7(2):e31919. PubMed ID: 22384099
[TBL] [Abstract][Full Text] [Related]
16. Metastatic neuroblastoma cancer stem cells exhibit flexible plasticity and adaptive stemness signaling.
Pandian V; Ramraj S; Khan FH; Azim T; Aravindan N
Stem Cell Res Ther; 2015 Feb; 6(1):2. PubMed ID: 25888913
[TBL] [Abstract][Full Text] [Related]
17. Novel therapies against aggressive and recurrent epithelial cancers by molecular targeting tumor- and metastasis-initiating cells and their progenies.
Mimeault M; Batra SK
Anticancer Agents Med Chem; 2010 Feb; 10(2):137-51. PubMed ID: 20184544
[TBL] [Abstract][Full Text] [Related]
18. Reprogramming during epithelial to mesenchymal transition under the control of TGFβ.
Tan EJ; Olsson AK; Moustakas A
Cell Adh Migr; 2015; 9(3):233-46. PubMed ID: 25482613
[TBL] [Abstract][Full Text] [Related]
19. Telomerase reverse transcriptase promotes epithelial-mesenchymal transition and stem cell-like traits in cancer cells.
Liu Z; Li Q; Li K; Chen L; Li W; Hou M; Liu T; Yang J; Lindvall C; Björkholm M; Jia J; Xu D
Oncogene; 2013 Sep; 32(36):4203-13. PubMed ID: 23045275
[TBL] [Abstract][Full Text] [Related]
20. Recent advances in cancer stem/progenitor cell research: therapeutic implications for overcoming resistance to the most aggressive cancers.
Mimeault M; Hauke R; Mehta PP; Batra SK
J Cell Mol Med; 2007; 11(5):981-1011. PubMed ID: 17979879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
